Cardiac surgery including hypothermic cardiac arrest (HCA) commonly involves perioperative
transfusion of allogeneic blood products which is associated with increased morbidity and
mortality. In this retrospective analysis, the investigator aimed to evaluate the effect of a
thromboelastometry-guided treatment algorithm promoting fibrinogen concentrate as first line
hemostatic agent on the perioperative use of allogeneic blood products.